(Q46695505)

English

Effect of ADRB2 polymorphisms on the efficacy of salmeterol and tiotropium in preventing COPD exacerbations: a prespecified substudy of the POET-COPD trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/24461901

Effect of ADRB2 polymorphisms on the efficacy of salmeterol and tiotropium in preventing COPD exacerbations: a prespecified substudy of the POET-COPD trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/24461901

chronic obstructive pulmonary disease

1 reference

based on heuristic

inferred from title

Leonardo M. Fabbri

2

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/24461901

author name string

Klaus F Rabe

1

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/24461901

Elliot Israel

3

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/24461901

Harald Kögler

4

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/24461901

Kathrin Riemann

5

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/24461901

Hendrik Schmidt

6

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/24461901

Thomas Glaab

7

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/24461901

Claus F Vogelmeier

8

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/24461901

publication date

5 December 2013

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/24461901

The Lancet. Respiratory medicine

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/24461901

2

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/24461901

1

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/24461901

44-53

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/24461901

Pharmacogenetics of chronic obstructive pulmonary disease: challenges and opportunities

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970248-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The pharmacogenetics and pharmacogenomics of asthma therapy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970248-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular mechanisms of beta(2)-adrenergic receptor function, response, and regulation

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970248-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of ADRB2 polymorphisms on response to longacting beta2-agonist therapy: a pharmacogenetic analysis of two randomised studies

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970248-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Beta2-receptor polymorphisms in patients receiving salmeterol with or without fluticasone propionate

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970248-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970248-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Interactions between corticosteroids and beta agonists

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970248-0

7 January 2021

based on heuristic

inferred from DOI database lookup

beta-Adrenergic receptor polymorphisms and response to salmeterol

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970248-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of beta2-adrenergic receptor polymorphism on response to longacting beta2 agonist in asthma (LARGE trial): a genotype-stratified, randomised, placebo-controlled, crossover trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970248-0

7 January 2021

based on heuristic

inferred from DOI database lookup

ADRB2 polymorphisms and budesonide/formoterol responses in COPD.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970248-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Polymorphisms in the beta2 adrenergic receptor and bronchodilator response, bronchial hyperresponsiveness, and rate of decline in lung function in smokers

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970248-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Lung function response to 12-week treatment with combined inhalation of long-acting beta2 agonist and glucocorticoid according to ADRB2 polymorphism in patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970248-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Association of beta2-adrenoreceptor genotypes with bronchodilatory effect of tiotropium in COPD.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970248-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Beta2-adrenergic receptor genetic polymorphisms and short-term bronchodilator responses in patients with COPD.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970248-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetic association analysis of COPD candidate genes with bronchodilator responsiveness

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970248-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Tiotropium versus salmeterol for the prevention of exacerbations of COPD.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970248-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A pharmacogenetic study of ADRB2 polymorphisms and indacaterol response in COPD patients

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970248-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and tolerability of budesonide/formoterol in one hydrofluoroalkane pressurized metered-dose inhaler in patients with chronic obstructive pulmonary disease: results from a 1-year randomized controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970248-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of budesonide and formoterol in one pressurized metered-dose inhaler in patients with moderate to very severe chronic obstructive pulmonary disease: results of a 6-month randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970248-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Seasonal distribution of COPD exacerbations in the Prevention of Exacerbations with Tiotropium in COPD trial.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970248-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of discontinuation of inhaled corticosteroids in patients with chronic obstructive pulmonary disease: the COPE study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970248-0

7 January 2021

based on heuristic

inferred from DOI database lookup

β2-adrenergic receptor polymorphisms, asthma and COPD: two large population-based studies

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970248-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Influence of beta 2-adrenergic receptor genotypes on signal transduction in human airway smooth muscle cells.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970248-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Once-daily indacaterol versus tiotropium for patients with severe chronic obstructive pulmonary disease (INVIGORATE): a randomised, blinded, parallel-group study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970248-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Polymorphisms of the beta2-adrenergic receptor and asthma

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970248-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S2213-2600(13)70248-0

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/24461901

release_q5lbuqrrnvb2pgermiuws32vxu

1 reference

https://api.fatcat.wiki/v0/release/q5lbuqrrnvb2pgermiuws32vxu

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/24461901

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46695505&oldid=2127255418"